IDRF/ AR Hopsitals
Chennai, Tamil Nadu, 600008, India
NCT Number: NCT01816906
This particular trial is looking to compare the effectiveness of two types of foot bed/ sole materials used within diabetic footwear.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Chennai, Tamil Nadu, 600008, India
DiaBSmart as a project aims to generate, transfer and exchange the clinical, academic and production knowledge between the partners to create a new generation of diabetic footwear through a newly developed patient assessment system. The transfer of knowledge between various sectors ensures that the need of patients is considered and transferred effectively to product development using a scientific approach. The objectives include:(1) the design and development of an integrated system of DIABetic foot assessment (2) to validate the newly developed system using experimental methods (3) to develop a suitable material to meet the mechanical and clinical requirements (4) to evaluate the mechanical and clinical effectiveness of material choice in reducing the potential risk of foot complications. The Numerical, Experimental and Mathematical Analyses system will integrate all aspects of diabetic footwear including; clinical and biomechanical assessment, material choice and aesthetic design. Proposed interdisciplinary, inter-sectorial approach is unique and brings together the expertise from research institutions, industry and clinics. This project while enhancing the knowledge base in diabetic assessment; will have a clear impact on new product development leading to both clinical and economic benefits. The products include a new generation of integrated SMART /multi material midsoles and/or orthoses for diabetic footwear. Properties of the materials will be optimised with a view to minimise/ redistribute the pressure and hence the stress on the soft tissue in the critical plantar areas of the foot. Whilst significantly affecting the course of the disease, the products will aim to reduce the risk of limb loss in patients with diabetes, the most frequent cause of non-traumatic lower-limb amputations.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
One group of patients will receive "Footwear" with PU insoles
One group of patients will receive footwear with MCP insoles
Time frame: 6 months
Postural sway was recorded while standing on a pressure mat with eyes open for 30 seconds.
Area of the center of pressure excursion
Time frame: Up to 6 months
Strength during dorsi flexion using Citec Dynamometer
Time frame: Up to 6 months
Strength during plantar flexion using Citec Dynamometer
Time frame: Up to 6 months
Strength during dorsi flexion using Citec Dynamometer
Time frame: Up to 6 months
Strength during plantar flexion using Citec Dynamometer
Time frame: Up to 6 months
Average of left and right (8 measurement areas per foot)
Staffordshire University
Other
Development of a New Generation of DIABetic Footwear Using an Integrated Approach and SMART Materials
Acronym: DiaBSmart
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06518486
Cardiovascular Diseases, Diabetes
Batang, Central Java, Indonesia
View Trial DetailsNCT02169167
Cardiovascular Diseases, Diabetes Complications
Gdansk, Gdańsk, Poland
View Trial DetailsNCT05159856
Arterial Stiffness, Autoimmune Diseases
Herlev, Denmark
View Trial DetailsNCT06674980
Cardiovascular Diseases, Diabetes Complications
Metairie, Louisiana, United States
View Trial Details